Ifosfamide-induced Encephalopathy With Rapid Response to Thiamine: A Pediatric Case.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002473
Abstract: Ifosfamide is an important chemotherapeutic agent used in the therapeutic protocols of many malignant tumors. Central nervous system toxicity of ifosfamide manifests with encephalopathy in 10% to 30% of patients treated with ifosfamide. Thiamine and… read more here.
Keywords: thiamine; encephalopathy rapid; ifosfamide induced; ifosfamide ... See more keywords
Ifosfamide induced encephalopathy in a child with osteosarcoma
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220963545
Abstract: Background Ifosfamide (IFO) is an alkylating agent used to treat broad range of malignancies. One of the life-threatening toxic effects is reversible neurotoxicity. In this report; we presented a case report of ifosfamide induced encephalopathy… read more here.
Keywords: induced encephalopathy; ifosfamide induced; child osteosarcoma; ifosfamide ... See more keywords
Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Investigative Medicine High Impact Case Reports"
DOI: 10.1177/2324709618786769
Abstract: Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical presentation can range from mild symptoms such as acute confusion to non-convulsive seizures, severe irreversible coma, and death. The benefit of methylene… read more here.
Keywords: induced metabolic; ifosfamide induced; methylene blue; metabolic encephalopathy ... See more keywords